(Q50160651)

26 February 2018

title

Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis. (English)

1 reference

26 February 2018

1 reference

1 reference

Kilmartin DJ

1

1 reference

26 February 2018

Forrester JV

series ordinal

2

1 reference

26 February 2018

Dick AD

series ordinal

3

1 reference

26 February 2018

publication date

1 June 1998

1 reference

26 February 2018

Ocular Immunology and Inflammation

published in

1 reference

26 February 2018

volume

6

1 reference

26 February 2018

issue

2

1 reference

26 February 2018

page(s)

101-109

1 reference

26 February 2018

Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?

cites work

1 reference

https://api.crossref.org/works/10.1076%2FOCII.6.2.101.4051

Short term immunosuppressive therapy and long-term immunoregulation: promises and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.6.2.101.4051

Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.6.2.101.4051

Immunophilins, Heat Shock Proteins, and Glucocorticoid Receptor Actions in Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.6.2.101.4051

Stabilization in vitro of the untransformed glucocorticoid receptor complex of S49 lymphocytes by the immunophilin ligand FK506.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.6.2.101.4051

Preclinical and clinical study of FK506 in uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.6.2.101.4051

International consensus recommendations on cyclosporin use in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.6.2.101.4051

Systemic immunosuppressive therapy and the occurrence of malignancy in patients with ocular inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.6.2.101.4051

Effects of a new immunosuppressive agent, FK 506, on the efferent limb of the immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.6.2.101.4051

A clinical trial of FK506 in refractory uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.6.2.101.4051

FK506 treatment of noninfectious uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.6.2.101.4051

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.6.2.101.4051

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.6.2.101.4051

Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.6.2.101.4051

10.1076/OCII.6.2.101.4051

21 January 2018

Identifiers

DOI

1 reference

26 February 2018

release_wx3cnyvnqngthbboor7yowtzhe

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wx3cnyvnqngthbboor7yowtzhe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

26 February 2018